Related Experiment Video

Updated: Aug 30, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Berberine-induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human

K S Chang1, C Gao, L C Wang

  • 1Laboratory of Cellular Oncology, National Cancer Institute, NIH, Bethesda, MD 20892.

Cancer Letters
|December 3, 1990
PubMed

Insights

Berberine rapidly induces human teratocarcinoma cells to differentiate into neuronal cells, a process faster than retinoic acid. This differentiation involves down-regulating the protooncogene c-Ki-ras2.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Neuroscience

Background:

  • Teratocarcinoma cell lines, like NT2/D1, are valuable models for studying cellular differentiation.
  • Retinoic acid (RA) is a known inducer of neuronal differentiation in some teratocarcinoma models.
  • Understanding the molecular mechanisms of differentiation is crucial for regenerative medicine and cancer research.

Purpose of the Study:

  • To investigate the potential of berberine to induce neuronal differentiation in human teratocarcinoma cells.
  • To compare the efficacy and speed of berberine-induced differentiation with retinoic acid.
  • To explore the molecular changes, specifically c-Ki-ras2 gene expression, associated with berberine-induced differentiation.

Main Methods:

  • Treatment of NT2/D1 pluripotent human teratocarcinoma cells with berberine (0.1 mg/ml) for 24 hours.
  • Morphological assessment of cellular differentiation into neuronal cell types.
  • Comparison of differentiation kinetics with retinoic acid treatment.
  • Analysis of c-Ki-ras2 and actin mRNA expression levels using RT-PCR or similar techniques.

Main Results:

  • Berberine rapidly induced NT2/D1 cells to differentiate into neuronal cells within 1 day, forming interconnected networks.
  • This differentiation process was significantly faster than that induced by retinoic acid.
  • Berberine did not induce endodermal differentiation in murine F9 teratocarcinoma cells.
  • Neuronal differentiation was associated with a marked down-regulation of c-Ki-ras2 mRNA expression, while actin mRNA levels remained unchanged.

Conclusions:

  • Berberine is a potent and rapid inducer of neuronal differentiation in human teratocarcinoma cells.
  • The mechanism of berberine-induced differentiation involves the down-regulation of the protooncogene c-Ki-ras2.
  • Berberine offers a potentially faster alternative to retinoic acid for inducing neuronal differentiation, with implications for cancer research and neurogenesis studies.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...